Acadia Pharmaceuticals ACAD Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $177.7M-44.4% | $319.59M+69.4% | $188.66M+64.3% | $114.85M-22.1% | ||
| $641.99M+47.1% | $436.4M+74.4% | $250.21M-17.1% | $301.98M-19.1% | ||
| $121.46M+23.0% | $98.74M+0.5% | $98.27M+58.0% | $62.2M-3.4% | ||
| $4.89M+10.6% | $4.42M-70.6% | $15.07M+4,960% | -$310K— | ||
| $1.06B+13.2% | $938.32M+52.3% | $616.13M+21.3% | $507.94M-17.8% | ||
| $7.51M+78.2% | $4.22M-8.6% | $4.61M-23.4% | $6.02M-25.2% | ||
| $108.89M-9.1% | $119.78M+82.9% | $65.49M— | $0— | ||
| $1.56B+31.7% | $1.19B+58.6% | $748.96M+27.4% | $587.81M-16.0% | ||
| $277.11M-29.8% | $394.87M+55.3% | $254.25M+102% | $125.63M+30.8% | ||
| $336.81M-26.0% | $454.96M+43.4% | $317.2M+69.3% | $187.4M+17.7% | ||
| $16K0.0% | $16K0.0% | $16K0.0% | $16K0.0% | ||
| -$1.81B+17.7% | -$2.2B+9.3% | -$2.43B-2.6% | -$2.37B-10.0% | ||
| $1.23B+67.5% | $732.79M+69.7% | $431.76M+7.8% | $400.41M-26.0% | ||
| $1.56B+31.7% | $1.19B+58.6% | $748.96M+27.4% | $587.81M-16.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Acadia Pharmaceuticals's total assets?
- Acadia Pharmaceuticals (ACAD) holds $1.6B in total assets, up 41.8% year over year.
- How much debt does Acadia Pharmaceuticals have?
- Acadia Pharmaceuticals carries $50.8M in total debt against $1.2B of shareholders' equity, a debt-to-equity ratio of 0.04.
- How much cash does Acadia Pharmaceuticals have?
- Acadia Pharmaceuticals holds $282.2M in cash and equivalents.
- Can Acadia Pharmaceuticals cover its short-term obligations?
- Its current ratio is 3.59 — current assets exceed current liabilities.
- Where does Acadia Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Acadia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
